Member Info for AquaeSulis01

Slimbiome fad something fffing spell checker

mol, I'll offer you an alternative perspective on Nichola's story, and that is someone who started on Slimbiome to lose weight in 2020, lost enough weight to fit in her wedding dress, and just over 2 years later is still comfortable taking slimline as part of a regular regime and has now lost 4 stone in total. Not some dad diet but someone you can live with over time which tells quite a good story actually.

bel, the sp rose steadily on no news between the 5th Oct and 8th Nov 2022 on no news so I doubt a leak is responsible as already been told by SA that he runs a tight ship. My own theory is that investors have waited to see how sticky the hands were that took place in the main equity raise as there was always a danger that the shares would be forward sold into the market crashing the share price still further, no doubt the reason most of us pi's elected not to take part in the separate retail offer. Having seen share price stability, investors will now be more confident, especially as the company is now fully funded for the next year, and mindful that there should be positive rather than negative news ahead, it was a pretty dramatic share price fall from 26p on the 8th Nov to 17p (on 14th Dec) prior to the fund raise being announced on the 15th Dec again on no news.

Toyin none as long as 2023 sees the announcement of a crod a launch and multi national agreement.. Read the post properly.

Little harsh making the beer a condition of a 75p price restoration clio. The likely higher level of inflation and interests rates mean that NPV is very different now to 2021 and PE ratio a lot lower for growth companies. Delivering the multi national agreement for axis, and visibility of substantial royalties sooner rather than later in 2023 would warrant a beer or two for Stuart irrespective of the share price rise which is outside his control, else only fair that Stuart stands all LTH's a pint to explain why targets have been mis sed.

Thanks for posting mol. I am a form believer in the benefits of products such as slimbiome. My wife has previously suffered on a fairly regular basis from diverticulitis, however, since having the s lim expert porridge every morning over the last 3 years there have been no severe outbreaks (abdominal pain and diarrhoea) and I no longer have to declare it on insurance forms when we travel abroad. Might be worth the company exploring this as an additional benefit from the fibrous nature of slimbiome.

Must admit as someone who tends to buy in on what I see as very positive RNS's that do not attract the immediate market support the company deserves, this share is currently a bargain and ignoring the noise surrounding windfall tax the only headline that really matters is the overall impact on the cash generated
"LONDON, Jan 19 (Reuters) - Harbour Energy , the British North Sea's biggest oil and gas producer, forecast its 2022 cashflow to triple to $2.1 billion on the back of higher prices and despite a rise in tax bills, it said in a trading statement on Thursday.

Its overall tax payments last year more than doubled to $600 million and out of the $350 million UK windfall tax bill for 2022, Harbour said it would pay $150 million in 2023."
https://www.reuters.com/business/energy/harbour-energy-sees-its-2022-cash-flow-triple-21-bln-2023-01-19/

Hadn't realised how populous Saudi Arabia is "The current population of Saudi Arabia is 36,191,147 as of Wednesday, January 18, 2023"
https://www.worldometers.info/world-population/saudi-arabia-population
Also obesity rates are growing but the Country is determined to address the problem so all positives for Opti's Go-Figure launch.
"The rise of overweight and obesity has been particularly alarming in Saudi Arabia—The rate has nearly doubled over the past 50 years. Like in many other Gulf Cooperation Council countries, rapid economic development and urbanization have brought lifestyle changes including decreased physical activity and increased consumption of highly processed foods and beverages. As a result, more than 50 percent of the population in Saudi Arabia today is overweight (Figure 1), and more than 20 percent have obesity."
"Under its “Vision 2030,” Saudi Arabia is aiming for a 3 percent reduction in obesity and a 10 percent decrease in diabetes prevalence by 2030"
https://www.brookings.edu/blog/future-development/2022/12/15/countdown-to-2030-addressing-the-stubborn-obesity-challenge-in-saudi-arabia/

As the initial scale-up to 600 litres is enough to satisfy VIP Customers then evaluating the additional benefits is surely the only reason for the delay. This from the Mar 2022 Half Year Report RNS "Through the course of the collaboration, Sederma continues to identify additional potential scientific and marketing claims for the end ingredient. In parallel to the manufacturing scale-up process that Croda are progressing at its facility near Widnes, Sederma is continuing its lab work to further substantiate any additional potential claims.

Croda has engaged with its VIP clients and management continues to anticipate licensed royalty revenue generation by the end of 2022."

What we don't know regarding the wider launch is whether the final scale-up to 20000 litres allowing the remaining non-VIP clients to evaluate the lysate, has been achieved yet bearing in mind it took Opti's US Partner several months to fully optimise their final scale-up once it had been achieved

Gig, were the same conspiracies going around the Board when Lombard sold over 7M shares at 34p in July 2022?
https://www.pilling.co.uk/home/profiles/news-and-research/external-news/article/?category=dealings-round-up&slug=director-dealings-nanoco-director-linked-to-pound17m-share-sale&story_id=10159430

Toyin, I'll believe the ship has sailed when I see a ground breaking sweetener good for the gut rather than destroying good gut bacteria, stocked on the shelf in Supermarkets instead of sugar, the T&L deal with Quantum was more about gaining access to the Chinese Market for their own products rather than any revolutionary sweetening products I suspect.
Clio, neither SOH or Stuart have any say over when products are launched by their respective partners so there is a doubt over which will be first, however, as an owner of both stocks I'll be delighted with whoever is first over the line.
Farris, nothing negative in TW's bearcast re the Stuart email other than some minor grammar corrections

On one of the Investor Meets presentation slides

TW has exchanged emails with Stuart about lack of news regarding the Crod a meetings in Dec and this month. Nothing Stuart is allowed to report so unlikely any impending launches although TW has taken it as a positive that there appears to be no disappointing feedback from Croda's end Customers as that would need to be RNS 'd. Think I'll have a side bet with elrico over whether sweetbiotix or skinbiotix launches first. I know elric believes sweetbiotix will need to go through extended retesting now final scale up has been achieved, but as one of the potential end customers was named aS Tate and Lyle, then nothing to stop ignoring sold to go straight in your coffee or tea I would have thought.

Showing your age there Toyin with Commodore 64 :). Mind you m y first home computer was a ZX Spectrum, wait 5 minutes for a game on a tape to load up and half the time it would crash 4 minutes in.

Toyin you have obviously never done any computer programming. If the acquisition was to be funded either by debt or equity then no and statement would be necessary, so yes we will need some sort of equity raise if the acquisition goes ahead. Plus whilst the potential acquisition is currently profitable, would be worth checking if it is forecast to remain profitable in the current climate or have revenues and profits declined 2022 when compared to 2021 along with many other companies?

and Flyinghigher had the settlement in the billions when he was a bull back in July

Toyin, so we need to sell ourselves in the medium term because a deal with a multi national that we sacrificed £1.2M early revenue for is likely years away whilst those other products with our science in them go through R&D and consumer studies which I guess is no surprise seeing as mediclinic "early discussions" mentioned in the placing RNS have been at that very early stage for over 2 years now. From Dec 2020 Results RNS "Management also believes there is utility for the technology in the treatment of various classes of skin wounds and is in discussion with a number of global advanced woundcare companies in this regard. The Company is targeting a commercial agreement to develop and test the SkinBiotix® technology in these indications."

Regarding the equity raise also from the placing RNS "However, there is no certainty of timing or execution as the Company would need to agree additional funding using debt and/or equity and any acquisition would be conditional on satisfactory diligence." notice the and or following debt which means either entirely funded by an equity raise or partially funded with an equity raise alongside debt.

In case anyone missed this morning's RNS
January 17th 2023

"New Gold 'Showing' on the Enable claim block, Ontario

First Class Metals PLC ("First Class Metals" "FCM" or the "Company") the UK metals exploration company seeking large scale metal discoveries across its extensive Canadian Schreiber-Hemlo land holding and the Sunbeam Project, is pleased to announce an operational update for the Enable Project, west of Marathon, Ontario.

First Class Metals is now in receipt of the first assay results from the 2022 field campaign and accordingly provides an operational update initially for Enable, which includes the announcement of a new gold showing now defined on the property.

This is the first in a series of releases which will report the success of the field season activities for 2022 across the six properties worked upon. All field work was carried out under stewardship of Emerald Geological Services (EGS), led by their principal Bruce MacLachlan.



Highlights

· Field work identified a new gold (Au) with significant silver (Ag) 'showing' on the property.

· Rock grab samples of over 7ppm (Au)[1] and significant Ag values are reported

· The historic West Perch Lake showing of ~2ppm Au confirmed and expanded.

· An exploration permit application is being drafted which will allow 'mechanical exploration' including drilling.

· FCM Ontario Winter 2023 exploration campaign underway with lake sediment sampling on Enable planned."

Must admit bel I am less than thrilled with the prospect of an acquisition fuelled by a further equity raise and a little puzzled over where it fits into the future strategy of using Multi National Partners to sell at pillar level. There even appears to be conflicting statements in the Year End RNS that in one place stated "Post year end, sales have continued to increase albeit still at a slow pace, however, the retention rate of approximately 80% on a monthly basis supports management's belief of the long-term potential for the AxisBiotix-Ps™ product. The Board believes it is in the interests of the Company and a better way to generate long term value to its shareholders to seek to secure an exclusive deal with a global multinational for AxisBiotix-Ps™, rather than signing multiple distribution deals across different markets. " , and yet further in when speaking about Acne (part of the Axisbiotix Pillar) "Acne

The next product in development under the AsixBiotix pillar is one targeting acne. Early signs of efficacy were seen in the participant study with benefits reported by people suffering from other conditions, from acne, rosacea and eczema.



During the year, the Group has been developing a new bacterial blend. Management is pleased to report that the pilot formulation is stable and it is looking to design a consumer study in the same form as the BRIGHT study for Axis-Biotix-Ps™. This study is anticipated to commence during 2023. In the meantime, the team is assessing the options for the most appropriate commercialisation strategy, on the basis of a positive outcome."
Well surely, if the decision has been made to pursue a Multi National Partner approach the options have already been assessed and decided on?

Ah so that's who the green box is, elrico's stalker. Not sure why you continue to feel the need to respond Toyin after all judging by the comments in your and others responses there does not appear to be any new material in the attacks, in fact judging by Clio's £70K quote (which I presume hasn't been assumed to be the revenue figure until the end of 2022) it doesn't even appear to be accurate so why bother?